Masahiro Amakawa

Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)

Ryousuke Fukui, Nobuhiko Shibata, Eiko Kohbayashi et al. · Atherosclerosis · 1997 · 44 citations

Life Sciences, Cell Biology, Molecular Biology +14

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration

Yusuke Watanabe, Masahiro Amakawa, Yoshihide Miyake et al. · European Journal of Pharmacology · 2015 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate

Daisuke Furutama, Ryousuke Fukui, Masahiro Amakawa et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1998 · 26 citations

Life Sciences, Cell Biology, Pharmacology +14

Increased migration in late G₁ phase in cultured smooth muscle cells

Ryosuke Fukui, Masahiro Amakawa, Masaaki Hoshiga et al. · American Journal of Physiology-Cell Physiology · 2000 · 20 citations

Life Sciences, Cell Biology, Molecular Biology +10

Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion

Yasutaka Murahashi, Fumiko Yano, Ryota Chijimatsu et al. · Scientific Reports · 2019 · 20 citations · Full text

Dentistry, Orthopaedic Surgery, Orthopedic Surgery +15